Developing the world's first Hendra vaccine

In 1994, a deadly new virus threatened to stop Australia's premier horse race – the Melbourne Cup. Over the next 16 years, 18 outbreaks of the now infamous Hendra virus were recorded through Queensland and NSW.

The Challenge

A mystery virus

In September 1994, prominent Queensland horse trainer Vic Rail, his stable hand, and most of his horses fell ill to a sudden and mysterious illness. Within several days, Mr Rail and 14 horses were dead.

Electron micrograph of Hendra virus.

The (then) Queensland Department of Primary Industries (QDPI) collected specimens from affected race horses and submitted them for testing at CSIRO's Australian Animal Health Laboratory (AAHL) in Geelong, Victoria.

Since the first identified Hendra virus incident seven people have been confirmed to have been infected with Hendra virus, four of whom have died as a result of the disease.

Our Response

Road to finding a vaccine

AAHL has been actively involved and has worked closely with QDPI and Queensland Health in each recorded Hendra virus incident since it first emerged in 1994. 

In 1994 AAHL's diagnostic team isolated and identified what proved to be a new virus that had not been previously reported anywhere else in the world. Researchers initially named the virus equine morbillivirus, however, further genetic analysis showed that the most appropriate classification of the virus was to place it in a new genus within the family Paramyxoviridae.

It was later renamed Hendra virus, after the name of the Brisbane suburb in which the original outbreak occurred.

With the cause of the disease outbreak known, AAHL researchers developed diagnostic tests. At the time QDPI, Queensland Health and AAHL tested more than 2500 horse samples and 150 human samples, however, they did not find any new cases.

As a National Facility, AAHL provides diagnosis of emergency animal diseases, which includes:

  • index case confirmation
  • national emergency response capability
  • use of accredited and validated tests.

The strength of AAHL's capabilities was clearly demonstrated by the manner in which the infectious agent was isolated, the disease reproduced in horses and the virus eventually identified using electron microscopy and gene sequence analysis, all completed within two weeks.

From 1994 - 2010, 14 clusters of Hendra virus infection were recorded in horses.

Then in 2011, Australia witnessed an unprecedented spike in the number of Hendra virus cases in horses in both Queensland and New South Wales with 18 outbreaks and 24 cases in horses reported. 2011 was also the year that the first dog tested positive to the Hendra virus. This unexpected transmission to a new species prompted an additional $6 million in Government funding towards Hendra virus research.

In July of the same year, the first confirmed outbreak of Hendra virus west of the Great Dividing Range was reported in Chinchilla, shattering perceptions that inland horse communities were safe from the virus.

The science community agreed that a vaccine specifically targeting horses was crucial to breaking the cycle of Hendra virus transmission from animals to people, as it would prevent the horse developing the disease and passing it on.

The Results

Equivac® HeV

In May 2011 CSIRO announced the development of a prototype vaccine for horses.  Following rigorous safety testing CSIRO, along with its partners launched the Equivac HeV vaccine in November 2012. By March 2013 our scientists confirmed that horses were immune to a lethal exposure of the Hendra virus six months post vaccination.

The Equivac® HeV is a world-first commercial vaccine for a Bio-Safety Level-4 disease agent. This vaccine enables commercial and private equine activities to continue with minimal negative impact by increasing personal safety for horse owners, vets and others regularly interacting with horses. It also enhances security for the Australian horse industry and reduces time spent in quarantine.

The vaccine has reduced costs attributed to future disease response and containment and minimised the chances of the Hendra virus mutating and spreading more readily between horses, or from human to human.

The Australian Veterinary Association now recommends that all horses in Australia are vaccinated against the Hendra virus.

In August 2015 the Australian Pesticides and Veterinary Medicines Authority (APVMA) announced it has now fully registered the Hendra virus vaccine , Equivac® HeV, following a detailed assessment process, with the vaccine meeting every assessment criteria for registration.

Enquiries

Have an enquiry about this page?

Contact us

Want to join the team of experts working at CSIRO?

We pride ourselves on recruiting the best minds in Australia and around the world, where creativity and skill match enthusiasm for science and discovery.

See if there’s a job for you